$DARE
Dare Bioscience, Inc.

2020 Q4 Form 10-Q Financial Statement

#000140191420000118 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.800M $1.380M $1.490M
YoY Change 20.81% -4.83% 14.62%
% of Gross Profit
Research & Development $6.640M $6.204M $2.370M
YoY Change 180.17% 215.52% 42.77%
% of Gross Profit
Depreciation & Amortization $0.00 $20.00K $10.00K
YoY Change -100.0%
% of Gross Profit
Operating Expenses $8.440M $7.582M $3.860M
YoY Change 118.65% 121.78% 30.41%
Operating Profit -$7.582M
YoY Change 121.78%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 -$986.00 -$10.00K
YoY Change -100.0% -103.87% -125.0%
Pretax Income -$8.440M -$7.580M -$3.870M
YoY Change 118.09% 123.6% 32.53%
Income Tax
% Of Pretax Income
Net Earnings -$8.440M -$7.583M -$3.870M
YoY Change 118.09% 123.48% 32.53%
Net Earnings / Revenue
Basic Earnings Per Share -$0.24
Diluted Earnings Per Share -$220.8K -$0.24 -$214.4K
COMMON SHARES
Basic Shares Outstanding 37.99M shares 31.59M shares 16.68M shares
Diluted Shares Outstanding 31.59M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.670M $5.390M $4.780M
YoY Change -2.3% 120.9% -29.81%
Cash & Equivalents $4.669M $5.389M $4.780M
Short-Term Investments
Other Short-Term Assets $1.850M $1.380M $1.110M
YoY Change 66.67% 79.22%
Inventory
Prepaid Expenses $1.854M $1.381M $1.109M
Receivables
Other Receivables $460.2K $213.6K $555.2K
Total Short-Term Assets $6.984M $6.984M $6.444M
YoY Change 8.38% 115.34% -11.0%
LONG-TERM ASSETS
Property, Plant & Equipment $37.93K $42.35K $63.53K
YoY Change -40.3% 617.17% 576.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $528.9K $635.0K $935.3K
YoY Change -43.46% 0.36% 61.83%
Total Long-Term Assets $566.8K $677.3K $998.9K
YoY Change -43.26% 6.07% 70.06%
TOTAL ASSETS
Total Short-Term Assets $6.984M $6.984M $6.444M
Total Long-Term Assets $566.8K $677.3K $998.9K
Total Assets $7.551M $7.662M $7.443M
YoY Change 1.45% 97.36% -4.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.021M $1.555M $1.083M
YoY Change -5.71% 344.37% 135.63%
Accrued Expenses $3.360M $2.454M $2.099M
YoY Change 60.09% 59.71% 232.41%
Deferred Revenue
YoY Change
Short-Term Debt $370.0K $370.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.661M $7.965M $5.612M
YoY Change 36.49% 321.67% 414.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $41.84K $1.080M $389.6K
YoY Change -89.26% 489.53% 3911.49%
Total Long-Term Liabilities $41.84K $1.080M $389.6K
YoY Change -89.26% 489.53% 3911.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.661M $7.965M $5.612M
Total Long-Term Liabilities $41.84K $1.080M $389.6K
Total Liabilities $8.702M $9.048M $7.002M
YoY Change 24.29% 336.66% 536.1%
SHAREHOLDERS EQUITY
Retained Earnings -$71.43M -$63.00M -$44.02M
YoY Change 62.26% 56.72% 51.96%
Common Stock $70.37M $61.72M $44.57M
YoY Change 57.9% 46.67% 24.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.152M -$1.386M $440.8K
YoY Change
Total Liabilities & Shareholders Equity $7.551M $7.662M $7.443M
YoY Change 1.45% 97.36% -4.91%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income -$8.440M -$7.583M -$3.870M
YoY Change 118.09% 123.48% 32.53%
Depreciation, Depletion And Amortization $0.00 $20.00K $10.00K
YoY Change -100.0%
Cash From Operating Activities -$9.190M -$5.360M -$3.810M
YoY Change 141.21% 68.55% 40.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $6.140M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $6.140M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.450M 5.400M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -9.190M -5.360M -3.810M
Cash From Investing Activities 0.000 0.000 6.140M
Cash From Financing Activities 8.450M 5.400M 0.000
Net Change In Cash -740.0K 40.00K 2.330M
YoY Change -131.76% -101.26% -185.98%
FREE CASH FLOW
Cash From Operating Activities -$9.190M -$5.360M -$3.810M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$9.190M -$5.360M -$3.810M
YoY Change 141.21% 68.55% 40.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001401914
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsNoncurrent
CY2020Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
DARÉ BIOSCIENCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-36395
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4139823
dei Entity Address Address Line1
EntityAddressAddressLine1
3655 Nobel Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 260
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
926-7655
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92122
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
DARE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37990001 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5389414 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4780107 USD
CY2020Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
213560 USD
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
555210 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1381462 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1108615 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
6984436 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
6443932 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42349 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63531 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
634957 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
935325 USD
CY2020Q3 us-gaap Assets
Assets
7661742 USD
CY2019Q4 us-gaap Assets
Assets
7442788 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1555307 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1083183 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2454048 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2098653 USD
CY2020Q3 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
2178379 USD
CY2019Q4 dare Deferred Grant Funding Current
DeferredGrantFundingCurrent
2019674 USD
CY2020Q3 us-gaap Notes Payable Current
NotesPayableCurrent
367285 USD
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1000000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
409647 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
410896 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7964666 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5612406 USD
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1000000 USD
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1000000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
82964 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
389556 USD
CY2020Q3 us-gaap Liabilities
Liabilities
9047630 USD
CY2019Q4 us-gaap Liabilities
Liabilities
7001962 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33602516 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33602516 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19683401 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19683401 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
3360 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1968 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-112807 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-102625 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61712882 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
44564674 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62989323 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44023191 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1385888 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
440826 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7661742 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7442788 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1353069 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6203753 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6172192 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1966230 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14131007 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1318986 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4772382 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3903545 USD
CY2020Q3 dare License Fee
LicenseFee
25000 USD
CY2019Q3 dare License Fee
LicenseFee
133333 USD
dare License Fee
LicenseFee
58333 USD
dare License Fee
LicenseFee
408333 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
7581822 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
3418549 USD
us-gaap Operating Expenses
OperatingExpenses
18961722 USD
us-gaap Operating Expenses
OperatingExpenses
10484070 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7581822 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3418549 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18961722 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10484070 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-986 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25471 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2454 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86703 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7582808 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3393078 USD
us-gaap Net Income Loss
NetIncomeLoss
-18959268 USD
us-gaap Net Income Loss
NetIncomeLoss
-10397367 USD
CY2020Q3 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
6863 USD
CY2019Q3 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
0 USD
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
6863 USD
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
789594 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7589671 USD
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3393078 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18966131 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11186961 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
672 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15378 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10182 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15674 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7588999 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3408456 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18976313 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11202635 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.69
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.76
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31588152 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16683411 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27381508 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14756213 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
440826 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
160841 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5222687 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1665020 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-4252248 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-22944 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3214183 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
186859 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4022336 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7124213 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12090 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
311255 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194882 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5277622 USD
CY2020Q3 dare Stock Issued During Period Value Consideration For Commitment To Purchase Shares
StockIssuedDuringPeriodValueConsiderationForCommitmentToPurchaseShares
291529 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
120960 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7582808 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
672 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1385888 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6726620 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
97968 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3051840 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7621 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3780369 USD
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111351 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5151702 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-3952450 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7917 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5083055 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
135393 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-3393078 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
472124 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15378 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1809992 USD
us-gaap Profit Loss
ProfitLoss
-18959268 USD
us-gaap Profit Loss
ProfitLoss
-10397367 USD
us-gaap Depreciation
Depreciation
36428 USD
us-gaap Depreciation
Depreciation
3491 USD
us-gaap Share Based Compensation
ShareBasedCompensation
542582 USD
us-gaap Share Based Compensation
ShareBasedCompensation
344712 USD
dare Non Cash Lease Expense
NonCashLeaseExpense
-125517 USD
dare Non Cash Lease Expense
NonCashLeaseExpense
-19914 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-341650 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
6802 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-18682 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
367409 USD
dare Increase Decrease In Other Non Current Assets And Deferred Charges
IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges
-118044 USD
dare Increase Decrease In Other Non Current Assets And Deferred Charges
IncreaseDecreaseInOtherNonCurrentAssetsAndDeferredCharges
-138719 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-107463 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
355395 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
905236 USD
dare Increase Decrease In Deferred Grant Funding
IncreaseDecreaseInDeferredGrantFunding
-158704 USD
dare Increase Decrease In Deferred Grant Funding
IncreaseDecreaseInDeferredGrantFunding
0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16041176 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9506797 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15246 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15246 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
dare Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
14522645 USD
dare Net Proceeds From Issuance Of Common Stock And Warrants
NetProceedsFromIssuanceOfCommonStockAndWarrants
5151702 USD
dare Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
1785980 USD
dare Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
367285 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16675911 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5151702 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10182 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-15674 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
609307 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4370769 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4780107 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6805889 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5389414 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2435120 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
231698 USD
dare Issuance Cost On Equity Paid In Common Stock
IssuanceCostOnEquityPaidInCommonStock
291428 USD
dare Issuance Cost On Equity Paid In Common Stock
IssuanceCostOnEquityPaidInCommonStock
0 USD
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
6863 USD
us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
789594 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63000000.0 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
16000000.0 USD
dare Periodof Insufficient Cashand Liquidity Requirements
PeriodofInsufficientCashandLiquidityRequirements
P12M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.20
CY2020Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
1493686 USD
dare Weighted Average Amortization Period
WeightedAverageAmortizationPeriod
P2Y4M13D
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0082
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.19
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.10
CY2018Q1 dare Percentage Of Aggregate Commission
PercentageOfAggregateCommission
0.03
CY2020Q2 dare Saleof Stock Maximum Amount Registered
SaleofStockMaximumAmountRegistered
7500000 shares
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.00
CY2020Q3 dare Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.000
dare Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.000
CY2019Q2 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.98
CY2020Q3 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.96
CY2019Q2 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
800000 USD
CY2020Q3 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
6863 USD
CY2020Q3 dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
126000 shares
CY2020Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
121000 USD
dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
1825000 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1800000 USD
dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
0 shares
CY2019Q3 dare Number Of Common Stock Warrants Exercised
NumberOfCommonStockWarrantsExercised
0 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1908643 shares
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
410000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
83000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
76000 USD
CY2018Q3 us-gaap Net Rentable Area
NetRentableArea
3169 sqft
CY2018Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2018Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.07
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
27000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
228000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
81000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
111000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
28000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
349000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
81000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M20D
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
493000 USD
CY2020Q2 dare Coronavirus Aid Reliefand Economic Security Act Loan Proceeds Received
CoronavirusAidReliefandEconomicSecurityActLoanProceedsReceived
367000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
24000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
112000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
363000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
42000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
517000 USD
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2020Q3 dare Notes Payable Current Plus Accrued Interest
NotesPayableCurrentPlusAccruedInterest
369000 USD
dare Proceeds From Award Of Grant
ProceedsFromAwardOfGrant
1900000 USD
CY2020Q2 dare Proceeds From Award Of Grant
ProceedsFromAwardOfGrant
731000 USD
CY2020Q3 us-gaap Grants Receivable
GrantsReceivable
69000 USD
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4692234 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5575808 shares

Files In Submission

Name View Source Status
0001401914-20-000118-index-headers.html Edgar Link pending
0001401914-20-000118-index.html Edgar Link pending
0001401914-20-000118.txt Edgar Link pending
0001401914-20-000118-xbrl.zip Edgar Link pending
dare-20200930.htm Edgar Link pending
dare-20200930.xsd Edgar Link pending
dare-20200930_cal.xml Edgar Link unprocessable
dare-20200930_def.xml Edgar Link unprocessable
dare-20200930_g1.jpg Edgar Link pending
dare-20200930_htm.xml Edgar Link completed
dare-20200930_lab.xml Edgar Link unprocessable
dare-20200930_pre.xml Edgar Link unprocessable
exhibit31120200930-ngv.htm Edgar Link pending
exhibit31220200930-ngv.htm Edgar Link pending
exhibit32120200930-ngv.htm Edgar Link pending
exhibit32220200930-ngv.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending